Aesgp, Efpia, and Medicines for Europe (the Pharmaceutical Industry Associations) have published a series of joint recommendations to support the implementation of electronic Product Information (ePI) and the improvement of the patient leaflet content. The gradual introduction of the ePI, which will replace the paper version within four years after entry into force of the revised General Pharma Legislation, will improve access to medication information, making it safer and more up-to-date. The transition will also offer more accessible formats, such as enlarged fonts and interactive content, ensuring options for those without internet access.
The optimization of patient information leaflets aims to simplify the availability of medication information, to improve the efficiency of regulatory processes, and to reduce environmental impact, promoting a more accessible, innovative, and safer healthcare system.